Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abdominal, accessing, allotted, announce, announced, annuity, arrangement, bid, book, broker, buy, cardiotoxicity, chemotherapeutic, CMO, conceived, concept, confirmation, Continental, counterpart, delist, delisted, delisting, documentary, fifteen, floor, Florida, foundation, fulfilled, ideal, indemnification, indemnify, IRC, justify, lapse, licensee, lifetime, mice, min, monetize, NGC, NOL, ovarian, prodrug, proforma, qualitative, quantitative, rarer, recharacterization, recharacterized, reelection, regain, reinstate, reissued, renewal, renewed, replicating, RSU, SD, sequelae, shift, slower, Spartan, startup, stop, symptomology, unamortized, unlisted, unused, unutilized, uptake, USPTO
Removed:
Accountant, Acthar, AGI, American, assisted, Atlantic, bachelor, Baltimore, bank, banking, Bay, Berkeley, billion, Biopharm, blood, bone, brokerage, building, built, capitalization, certified, CFO, chairman, close, closely, closer, closure, Coast, collapse, College, computing, conclude, conversion, correlation, CSO, daily, deadly, debilitating, deductible, deep, degeneration, Delaplaine, direction, disfiguring, DKBK, documented, dosed, dynamic, East, effected, Engineering, Equiniti, expert, expressing, Fellowship, forming, ft, Gel, George, GloboMax, Goldman, graduate, grew, GSE, Guy, Head, heading, healing, hired, Hood, ICON, idiopathic, importance, indeterminable, Infantile, initiating, Institute, instructor, investing, invited, IVIVC, joined, joining, Jose, Kellogg, leadership, lesion, limb, Lin, LOC, Madison, Mallinckrodt, manager, Master, MBA, men, Mercer, minimally, modernized, modernizing, Mount, natural, naturally, nature, NIH, nominal, outdated, par, pathophysiology, Patrick, people, pharmacologically, pharmacology, pharmacovigilance, Physiology, PIPE, planning, plc, prescribed, President, processing, professor, progression, projected, prolongation, protein, QTc, qualifying, ratably, ratchet, realization, remediate, remediated, rescind, retained, Robertson, San, School, scientist, Sector, serving, skin, software, solution, Southern, spent, sq, Stanker, Street, suggest, SUPAC, taught, Tenured, Thornton, threatening, timeframe, tissue, transient, transitioned, ulcer, ulcerated, ulceration, unrealized, Vice, visiting, voted, VP, Wachusett, Wall, Wendy, window, Wisconsin, women, wound
Filing tables
Filing exhibits
Associated PCSA transcripts
PCSA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-257558 and No. 333-254983) of Processa Pharmaceuticals, Inc. and Registration Statements on Form S-8 (No. 333-257557 and No. 333-233264) pertaining to the Processa Pharmaceuticals, Inc. 2019 Omnibus Equity Plan and (No. 333-190697) pertaining to the Heatwurx, Inc. 2011 Equity Incentive Plan of our report dated March 30, 2023, relating to the consolidated financial statements of Processa Pharmaceuticals, Inc. for the years ended December 31, 2022 and 2021 included in the Annual Report on Form 10-K of Processa Pharmaceuticals, Inc. for the year ended December 31, 2022.
/s/ BD & Company, Inc. | |
Owings Mills, MD | |
March 30, 2023 |